Pacira Shutters DepCyt Operations After Years of Manufacturing Problems

Drug Industry Daily
A A
Unable to resolve persistent manufacturing problems, New Jersey-based drugmaker Pacira Pharmaceuticals is ending production of its DepoCyt chemotherapy drug and closing the California plant where it is made.

To View This Article:

Login

Subscribe To Drug Industry Daily